Plagiarism Policy

Plagiarism Policy for "Journal of Drug Delivery and Biotherapeutics (JDDB)"

At "Journal of Drug Delivery and Biotherapeutics (JDDB)" we are committed to upholding the highest standards of academic integrity and ethical publishing. Plagiarism, which encompasses the use of someone else's ideas, words, or work without proper attribution, stands in direct violation of these principles. To safeguard the originality and authenticity of the research published in our journal, we have established the following Plagiarism Policy:

Definition of Plagiarism:

Plagiarism is defined as the act of presenting someone else's work, ideas, or words as one's own without providing appropriate credit to the original source. This includes, but is not limited to, the following:

  • Copying and pasting text from another source without adequate citation.
  • Paraphrasing or rephrasing another person's work without proper attribution.
  • Presenting significant portions of someone else's work as one's own.
  • Employing images, figures, tables, or other media without proper permission or citation.
  • Engaging in self-plagiarism, which involves republishing one's own previously published work without proper acknowledgment.

Editorial Review and Plagiarism Detection:

Every manuscript submitted to "Journal of Drug Delivery and Biotherapeutics (JDDB)" undergoes a rigorous editorial review process. As part of this process, we employ plagiarism detection software to meticulously assess the manuscripts for potential instances of plagiarism or inadequate citation. The software meticulously compares the submitted work with a comprehensive database of published materials and online sources.

Plagiarism Investigation:

In cases where plagiarism or any form of academic misconduct is suspected in a submitted manuscript, the editorial team will initiate a thorough investigation. This may involve a meticulous examination of similarities between the submitted work and existing publications, direct communication with the authors for clarification or explanation, and, when warranted, soliciting expert opinions.

Acceptable Similarity Range:

"Journal of Drug Delivery and Biotherapeutics (JDDB)" acknowledges that in certain instances, a degree of similarity may be unavoidable, particularly when properly citing and paraphrasing existing literature. Consequently, we allow a maximum similarity index of 10%, as determined by the plagiarism detection software. Any similarity exceeding this threshold will be considered potential plagiarism and subjected to further scrutiny.

Consequences of Plagiarism:

Should plagiarism be identified in a manuscript submitted to "Journal of Drug Delivery and Biotherapeutics (JDDB)" the following actions may be taken:

Rejection: The manuscript may be rejected without further evaluation, with authors receiving clear notification of the grounds for rejection.

Retraction: In cases where plagiarism is discovered in an already published article, it will be promptly retracted from the journal, with a clear retraction notice published, explicating the rationale behind the retraction.

Reporting: In instances of egregious plagiarism or recurrent violations, the matter may be reported to the authors' affiliated institutions, funding bodies, or relevant authorities for a thorough investigation and appropriate action.

Proper Citation and Attribution:

Authors submitting manuscripts to "Journal of Drug Delivery and Biotherapeutics (JDDB)" bear the responsibility of ensuring the originality of their work and providing precise and comprehensive citatio (JDDB)ns. Accurate and complete attribution must be given to all sources employed, encompassing direct quotations, paraphrased content, as well as ideas or concepts drawn from others.

Educational and Awareness Initiatives:

"Journal of Drug Delivery and Biotherapeutics (JDDB)" is steadfast in its commitment to fostering awareness and education on plagiarism and responsible research practices. We offer resources and guidelines to authors to promote proper citation, referencing, and the avoidance of plagiarism. Authors are encouraged to acquaint themselves with the ethical directives and policies of pertinent professional associations and institutions.

By implementing and enforcing this Plagiarism Policy, "Journal of Drug Delivery and Biotherapeutics (JDDB)" seeks to preserve the highest standards of integrity and originality in scientific research. Our goal is to safeguard the intellectual property rights of authors, promote a culture of academic honesty, and uphold the credibility and trustworthiness of the research disseminated in our journal.